15-58771706-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001040450.3(MINDY2):c.311G>A(p.Gly104Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000558 in 1,612,330 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001040450.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MINDY2 | NM_001040450.3 | c.311G>A | p.Gly104Glu | missense_variant | 1/9 | ENST00000559228.6 | NP_001035540.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MINDY2 | ENST00000559228.6 | c.311G>A | p.Gly104Glu | missense_variant | 1/9 | 2 | NM_001040450.3 | ENSP00000452885.1 | ||
MINDY2 | ENST00000450403.3 | c.311G>A | p.Gly104Glu | missense_variant | 1/9 | 1 | ENSP00000393231.2 | |||
MINDY2 | ENST00000316848.9 | n.311G>A | non_coding_transcript_exon_variant | 1/8 | 1 | ENSP00000326194.5 | ||||
MINDY2 | ENST00000560289.5 | n.311G>A | non_coding_transcript_exon_variant | 1/9 | 1 | ENSP00000453425.1 |
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152212Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000733 AC: 177AN: 241616Hom.: 0 AF XY: 0.000852 AC XY: 113AN XY: 132608
GnomAD4 exome AF: 0.000560 AC: 817AN: 1460000Hom.: 2 Cov.: 31 AF XY: 0.000607 AC XY: 441AN XY: 726338
GnomAD4 genome AF: 0.000538 AC: 82AN: 152330Hom.: 1 Cov.: 32 AF XY: 0.000537 AC XY: 40AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.311G>A (p.G104E) alteration is located in exon 1 (coding exon 1) of the FAM63B gene. This alteration results from a G to A substitution at nucleotide position 311, causing the glycine (G) at amino acid position 104 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at